日本語 
Eisai Co., Ltd. and Nuvation Bio Inc. have pushed taletrectinib into the next stage in Europe. The European Medicines Agency has validated the application. That basically means the file is…
KSK Unveils “Tsunagu TV” Health & Medical Platform
KSK Corporation will release the video platform "Tsunagu TV" in December. "Tsunagu…
Ubie and Kameda Hospital Start AI Obesity Treatment PoC
Ubie Inc. is pleased to announce that, in collaboration with Kameda General…
Eisai Seeks Approval for Subcutaneous LEQEMBI in Japan
Eisai and its global partner Biogen have filed a new drug application…
Kinko’s and Veeva Japan enter into partnership agreement
Veeva Japan Co., Ltd., the Japanese subsidiary of Veeva Systems, a global…
Japan speeds up My Number Card Digital Health Insurance
Japan is making fast inroads in digitizing its health insurance system by…
Otsuka Files FDA application for Centanafadine ADHD Drug
Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. announce…
AITRICS Launches Tokyo Office for Digital Health Growth
In a significant move for Japan's health-tech field, AITRICS, a medical AI…
ConcertAI Debuts TeraRecon AV for Smarter Med Imaging
ConcertAI rolled out TeraRecon AV, a new imaging platform built to cut…
English